301 related articles for article (PubMed ID: 28414587)
1. Non-melanoma skin cancer: new and future synthetic drug treatments.
Amaral T; Garbe C
Expert Opin Pharmacother; 2017 May; 18(7):689-699. PubMed ID: 28414587
[TBL] [Abstract][Full Text] [Related]
2. Update of cetuximab for non-melanoma skin cancer.
Wollina U
Expert Opin Biol Ther; 2014 Feb; 14(2):271-6. PubMed ID: 24387664
[TBL] [Abstract][Full Text] [Related]
3. Trends in incidence and survival analysis in non-melanoma skin cancer from 1994 to 2012 in Girona, Spain: A population-based study.
Rubió-Casadevall J; Hernandez-Pujol AM; Ferreira-Santos MC; Morey-Esteve G; Vilardell L; Osca-Gelis G; Vilar-Coromina N; Marcos-Gragera R
Cancer Epidemiol; 2016 Dec; 45():6-10. PubMed ID: 27639035
[TBL] [Abstract][Full Text] [Related]
4. Evolving Role of Systemic Therapies in Non-melanoma Skin Cancer.
Conforti C; Corneli P; Harwood C; Zalaudek I
Clin Oncol (R Coll Radiol); 2019 Nov; 31(11):759-768. PubMed ID: 31522944
[TBL] [Abstract][Full Text] [Related]
5. Oral therapy for nonmelanoma skin cancer in patients with advanced disease and large tumor burden: a review of the literature with focus on a new generation of targeted therapies.
Rudnick EW; Thareja S; Cherpelis B
Int J Dermatol; 2016 Mar; 55(3):249-58; quiz 256, 258. PubMed ID: 26566923
[TBL] [Abstract][Full Text] [Related]
6. Pharmacologic treatment options for advanced epithelial skin cancer.
Soura E; Chasapi V; Stratigos AJ
Expert Opin Pharmacother; 2015; 16(10):1479-93. PubMed ID: 26027692
[TBL] [Abstract][Full Text] [Related]
7. The efficacy of photodynamic therapy in treatment of recurrent squamous cell and basal cell carcinoma.
Farhadi M; Kamrava SK; Behzadi AH; Rafiezadeh P; Asghari A; Rezvan F; Maleki S
J Drugs Dermatol; 2010 Feb; 9(2):122-6. PubMed ID: 20214173
[TBL] [Abstract][Full Text] [Related]
8. New Perspectives in the Pharmacological Treatment of Non-Melanoma Skin Cancer.
Savoia P; Cremona O; Fava P
Curr Drug Targets; 2016; 17(3):353-74. PubMed ID: 26245477
[TBL] [Abstract][Full Text] [Related]
9. Management of non-melanoma skin cancer.
Lazareth V
Semin Oncol Nurs; 2013 Aug; 29(3):182-94. PubMed ID: 23958216
[TBL] [Abstract][Full Text] [Related]
10. Topical imiquimod or fluorouracil therapy for basal and squamous cell carcinoma: a systematic review.
Love WE; Bernhard JD; Bordeaux JS
Arch Dermatol; 2009 Dec; 145(12):1431-8. PubMed ID: 20026854
[TBL] [Abstract][Full Text] [Related]
11. Update on the Use and Treatment of Targeted Molecular Inhibitors for Locally Advanced and Metastatic Non-Melanoma Skin Cancers.
Odueyungbo M; Ratner D
Dermatol Surg; 2016 Jan; 42 Suppl 1():S49-56. PubMed ID: 26730974
[TBL] [Abstract][Full Text] [Related]
12. Risks of different skin tumour combinations after a first melanoma, squamous cell carcinoma and basal cell carcinoma in Dutch population-based cohorts: 1989-2009.
van der Leest RJT; Hollestein LM; Liu L; Nijsten T; de Vries E
J Eur Acad Dermatol Venereol; 2018 Mar; 32(3):382-389. PubMed ID: 28898461
[TBL] [Abstract][Full Text] [Related]
13. Changing pathology with changing drugs: skin cancer.
Karpova MB; Barysch MJ; Zipser MC; Schönewolf N; French LE; Dummer R
Pathobiology; 2011; 78(2):61-75. PubMed ID: 21677470
[TBL] [Abstract][Full Text] [Related]
14. Differential BMI1, TWIST1, SNAI2 mRNA expression pattern correlation with malignancy type in a spectrum of common cutaneous malignancies: basal cell carcinoma, squamous cell carcinoma, and melanoma.
Vand-Rajabpour F; Sadeghipour N; Saee-Rad S; Fathi H; Noormohammadpour P; Yaseri M; Hesari KK; Bagherpour Z; Tabrizi M
Clin Transl Oncol; 2017 Apr; 19(4):489-497. PubMed ID: 27718152
[TBL] [Abstract][Full Text] [Related]
15. Treatment of unresectable squamous cell carcinoma of the skin with epidermal growth factor receptor antibodies--a case series.
Eder J; Simonitsch-Klupp I; Trautinger F
Eur J Dermatol; 2013; 23(5):658-62. PubMed ID: 24135559
[TBL] [Abstract][Full Text] [Related]
16. Nation-wide survey of advanced non-melanoma skin cancers treated at dermatology departments in Japan.
Fujisawa Y; Funakoshi T; Nakamura Y; Ishii M; Asai J; Shimauchi T; Fujii K; Fujimoto M; Katoh N; Ihn H
J Dermatol Sci; 2018 Dec; 92(3):230-236. PubMed ID: 30527378
[TBL] [Abstract][Full Text] [Related]
17. Update in the treatment of non-melanoma skin cancers: the use of PD-1 inhibitors in basal cell carcinoma and cutaneous squamous-cell carcinoma.
Ascierto PA; Schadendorf D
J Immunother Cancer; 2022 Dec; 10(12):. PubMed ID: 36455990
[TBL] [Abstract][Full Text] [Related]
18. Topical imiquimod therapy for basal and squamous cell carcinomas: a clinical experience.
Tillman DK; Carroll MT
Cutis; 2007 Mar; 79(3):241-8. PubMed ID: 17674590
[TBL] [Abstract][Full Text] [Related]
19. Surgical management of giant skin tumor - A case report.
Usheva S; Vassilev I; Jelev G; Sedloev T; Dimitrov I; Terziev I; Boyadzhieva M; Milusheva Y; Troyanova P
Ann Chir Plast Esthet; 2024 Mar; 69(2):154-159. PubMed ID: 37423823
[TBL] [Abstract][Full Text] [Related]
20. [Skin cancer: from smearing to cutting].
Kelleners-Smeets NW; Bekkenk MW; de Haas ER
Ned Tijdschr Geneeskd; 2013; 157(12):A5602. PubMed ID: 23515035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
